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Abstract: Low back pain (LBP) is a leading cause of disability. It significantly impacts the patient’s
quality of life, limits their daily living activities, and reduces their work productivity. To reduce the
burden of LBP, several pharmacological and non-pharmacological treatment options are available.
This review summarizes the role of superficial heat therapy in the management of non-specific mild-
to-moderate LBP. First, we outline the common causes of LBP, then discuss the general mechanisms of
heat therapy on (LBP), and finally review the published evidence regarding the impact of superficial
heat therapy in patients with acute or chronic non-specific LBP. This review demonstrates that
continuous, low-level heat therapy provides pain relief, improves muscular strength, and increases
flexibility. Therefore, this effective, safe, easy-to-use, and cost-effective non-pharmacological pain
relief option is relevant for the management of non-specific mild or moderate low back pain in
current clinical practice.
Keywords: heat therapy; low-back pain; musculoskeletal pain; non-pharmacological management
1. Introduction
Low back pain (LBP) is an exceptionally common musculoskeletal problem and a
leading cause of disability [1]. LBP is experienced by most adults at some stage of their life,
with an estimated 577 million people affected in 2017 [1]. A recent systematic literature
review stated that the prevalence of LBP ranges from 1.4% to 20.0%, and the incidence
from 0.024% to 7.0% [2]. LBP significantly impacts patients’ quality of life, limiting their
daily activities and work productivity. Non-specific LPB therefore represents a substantial
clinical and economic burden, and is a major public health concern [1,3–7].
LBP is usually self-limiting, resolving in one to two months in most patients. Treat-
ments for non-specific LBP include both pharmacological and non-pharmacological in-
terventions [8]. Although over-the-counter, non-steroidal, anti-inflammatory drugs are
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frequently used as a first-line treatment for LBP [9,10], they carry the potential risk of cardio-
vascular, renal, hepatic, and gastrointestinal complications, particularly when used longer
term [11]. It should also be noted that LBP affects patients with different comorbidities,
which may place limitations on the use of concomitant pharmacological therapies [12].
The current guidelines for patients with mild-to-moderate LBP that does not limit ev-
eryday activity recommend that patients self-treat or use alternative, non-pharmacological
treatments, such as superficial heat, massage, acupuncture, or spinal manipulation as
initial or complementary options [8,13]. Heat therapy has been used for centuries to relieve
pain and promote health [14,15] and is applied today in a variety of forms, including heat
pads or wraps, hot baths, and heat lamps [16,17]. These modalities act at different depths,
with the collective action of reducing the muscle tone, increasing blood flow, and relieving
pain [17,18]. Continuous, low-level heat therapy is an effective, easy-to-use, low-cost option
that could be a valuable part of a multimodal analgesic strategy in current clinical practice,
and is a useful treatment that patients can easily and safely self-administer [19].
This narrative review summarizes the role of superficial heat therapy for the man-
agement of both acute and chronic non-specific LBP, focusing on the use of continuous,
low-level heat therapy administered directly to the skin via a heat wrap for patients with
mild-to-moderate LBP based on published studies and our collective clinical experience.
2. Causes of Low Back Pain
LBP results from—among other factors—activation of nociceptors in response to
trauma, tissue damage, or mechanical action on the spinal cord and spinal nerves, as well
as changes in (inflammatory) metabolism. Specialized, group III or group IV free nerve
endings (nociceptors) are polymodal [20,21], reacting to both mechanical influences and
inflammatory processes. These free nerve endings can produce inflammatory mediators
themselves (neurogenic inflammation amplification), which leads to a lowering of the
receptor threshold and an amplification of pain (peripheral pain sensitization) beyond the
primary cause [21].
“The changes in expression, distribution, and functioning of receptors and ionic
channels are thought to be a part of the neuroplasticity property, through which the
nervous system constantly adapts to external stimuli. Moreover, some of the reviewed
mediators have also been associated with ‘central sensitization’, a process that results in
pain chronification when the painful stimulation is particularly prolonged or intense, and
lastly leads to the memorization of the uncomfortable painful perception” [22].
Neurotransmitters elicit changes in the interneurons of the spinal dorsal horns that
influence their permeability, switching, and guidance mechanisms, which, in turn, affects
the way they relay stimuli (including pain) [23–27]. Depending on their location and the
cause of the activation of the pain receptors, there may be a local increase in the tone of the
segmentally assigned muscles, with the formation of trigger points. A permanent change
of the paravertebral muscle tone and the development of trigger points can lead to further
pain intensification and can result in a vicious circle of pain amplification. In this context,
Petrofsky et al. [28] showed that, when locally applied to trigger points, heat is significantly
superior to sham treatment for non-specific neck pain.
Although the cause of LBP is often non-specific, extensional and rotational-shear forces
acting on the spine can activate mechanical and polymodal pain receptors—especially in
spinal segments with pre-existing damage. The activation of nociceptors alters neuromus-
cular activation, resulting in muscle inhibition and contributing to a degenerative cascade,
which ultimately results in pain and limits the patient’s ability to move [29,30].
It is hypothesized that a low serum pH may drive LBP, as painful or damaged discs
have a lower pH than non-painful discs. A more acidic environment stimulates the
release of proinflammatory mediators and other inflammatory substances and depletes the
proteoglycan within discs. In turn, proinflammatory cytokines drive the release of nerve
growth factor, which facilitates the ingrowth of nerves into damaged discs and stimulates
the production of pain mediators. Ultimately, these inflammatory pathways may alter the
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intricate nutrient balance of the nucleus pulposus (the inner core of the vertebral disc),
leading to a reduced supply of oxygen, increased levels of lactate, and reduced pH, thereby
continuing the cycle, further disrupting the disc microenvironment and exacerbating the
pain stimulus [31,32].
Left untreated, a persistent stimulus can drive the transition from acute pain to
chronic pain via a series of distinct pathophysiological steps. Persistent pain can activate
secondary pathways that lead to peripheral and central sensitization, hindering normal
functioning via long-lasting modification of the neuronal cytoarchitecture and loss of
inhibitory interneurons [33,34]. It is therefore important that acute episodes of LBP are
addressed in a timely manner, and within the “window” in which permanent changes
may occur, to inhibit the transition to chronic pain [17,33]. Additionally, both chronic and
recurrent LBP can be associated with changes in the structure and function of the paraspinal
muscles (e.g., muscle degeneration and fat infiltration) that can compromise normal muscle
biomechanics and restrict movement; however, discussion of these musculoskeletal changes
is beyond the scope of this article.
3. Superficial Heat Therapy—How Does It Work?
The application of superficial heat is a non-pharmacological treatment approach that
involves the application of a heat source to the body to raise the local tissue temperature
(Figure 1). Heat therapy acts on pain and muscle spasms in multiple ways. The application
of low-level superficial heat activates temperature-sensitive nerve endings (thermorecep-
tors), which, in turn, initiate signals that block the processing of pain signals (nociception)
in the lumbar dorsal fascia and spinal cord [35]. In addition, the pressure used to apply
some superficial heat therapies, such as heat wraps, may activate the nerve endings that
detect changes in tissue pressure and movement (proprioceptors); when activated, the
proprioceptors block the transmission of pain signals to the spinal cord and the brain.
The analgesic effects of heat are partly mediated by transient receptor potential (TRP)
membrane channels, of which seven respond to heat and two respond to cold tempera-
tures. TRP vanilloid 1 (TRPV1) receptors facilitate the neural transduction of heat and the
processing of nociceptive pain. The activation of TRVP1 receptors in the brain is thought
to regulate anti-nociceptive pathways. These mechanisms serve to reduce muscle tonicity
and relax muscles, thereby reducing spasms and musculoskeletal pain and increasing
muscle flexibility [17,18,36].




Figure 1. Mechanism of action of superficial heat therapy on low back pain (based on [17,18,29]). 
In addition, an increase in temperature tends to reduce the stiffness in fascial tissues 
[37]. This effect may involve a decrease in the viscosity of hyaluronan, which restores nor-
mal gliding and normalizes the activity of the proprioceptive mechanoreceptors in the 
respective fascia [38]. An increase in thickness, together with reduced shear motion mo-
bility of the thoracolumbar fascia in chronic low back pain, has been documented as a 
possible correlate of fascial scarring [39,40]. The application of heat in low back pain pa-
tients may therefore also involve a normalizing effect on the thoracolumbar fascia [37]. 
An increase in tissue temperature via the application of heat packs leads to increased 
metabolism and vasodilation and accelerates the healing processes. An elevation in tissue 
temperature of just 1 °C is associated with a 10–15% increase in the local metabolism. 
Heat-dependent vasodilation increases the blood flow at the site of injury, facilitating 
healing through an enhanced supply of nutrients and oxygen, and via the removal of pain-
inducing mediators produced as a by-product of tissue damage. Connective tissues may 
also change in viscosity and density in response to heat, thereby improving the range of 
movement and enhancing tissue extensibility. Recent evidence also suggests that local-
ized, repeated heat therapy may promote an angiogenic environment and enhance muscle 
strength [17,18,29,41,42]. 
4. Overview of Superficial Heat Therapy Modalities 
Heat therapy is the therapeutic application of heat to the body that results in an in-
crease in tissue temperature [17]. The mode of therapy can be superficial, delivered using 
conduction (e.g., heat wraps or heat packs) or convection (e.g., hydrotherapy) techniques, 
or deep, delivered by conversion methods (e.g., ultrasound, diathermy, and laser ther-
apy). Table 1 summarizes the range of superficial low-level heat modalities available, all 
of which aim to provide pain relief and muscle relaxation/reduction in muscle spasms via 
the mechanisms described in the previous section [17,18]. Details on each of these heat 
therapy modalities and their specific applications are beyond the scope of this article, 
which is focused on the use of heat wrap therapy. 
Table 1. Types of superficial heat therapy used to treat acute or chronic back pain. 
 Method of Heat Application Type of Therapy 
Superficial heat therapy Conduction 
Heat wrap (wearable) 
Heat pack (grain) 
Hot water bottles 
Hot poultices 
Hot stone therapy 
Electric heat pads 
Figure 1. Mechanism of action of superficial heat therapy on low back pain (based on [17,18,29]).
In addition, an increase in temperature tends to reduce the stiffness in fascial tis-
sues [37]. This effect may involve a decrease in the viscosity of hyaluronan, which restores
normal gliding and normalizes the activity of the proprioceptive mechanoreceptors in
the respective fascia [38]. An increase in thickness, together with reduced shear motion
mobility of the thoracolumbar fascia in chronic low back pain, has been docume ted as
a possible correlate of fascial scarring [39,40]. The application of heat in ow b ck pa n
patients may therefore also involve a normalizing effect on the thoracolumbar fas ia [37].
An increase in tissue temperature via the applicatio of heat packs leads to increased
metabolism and vas dilation and accelerates the healing processes. An elevation in tissue
temperature of just 1 ◦C is ssociated with a 10–15% increase in the local metabolism.
Heat-dependent vasodilation increases the blood flow at the site of injury, facilitating
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healing through an enhanced supply of nutrients and oxygen, and via the removal of
pain-inducing mediators produced as a by-product of tissue damage. Connective tissues
may also change in viscosity and density in response to heat, thereby improving the
range of movement and enhancing tissue extensibility. Recent evidence also suggests that
localized, repeated heat therapy may promote an angiogenic environment and enhance
muscle strength [17,18,29,41,42].
4. Overview of Superficial Heat Therapy Modalities
Heat therapy is the therapeutic application of heat to the body that results in an
increase in tissue temperature [17]. The mode of therapy can be superficial, delivered using
conduction (e.g., heat wraps or heat packs) or convection (e.g., hydrotherapy) techniques,
or deep, delivered by conversion methods (e.g., ultrasound, diathermy, and laser therapy).
Table 1 summarizes the range of superficial low-level heat modalities available, all of
which aim to provide pain relief and muscle relaxation/reduction in muscle spasms via the
mechanisms described in the previous section [17,18]. Details on each of these heat therapy
modalities and their specific applications are beyond the scope of this article, which is
focused on the use of heat wrap therapy.
Table 1. Types of superficial heat therapy used to treat acute or chronic back pain.














One advantage of superficial heat therapy is its safety profile. In a Cochrane review
of nine studies, superficial heat therapy was associated with only minor adverse events,
mostly in the form of “skin pinkness” that resolved quickly [16]. Despite this, the use
of superficial heat therapy, especially at high temperatures, may carry the risk of burns
or skin ulceration. Furthermore, in some specific causes of pain, it may cause disease
complications, progression, or exacerbation of inflammation. Therefore, caution is re-
quired in any condition with sensory impairment, such as multiple sclerosis, spinal cord
injuries, autoimmune diseases with joint pain, activated osteoarthritis, poor circulation,
and cancer [43,44].
5. Evidence of the Effectiveness of Continuous Low-Level Heat Wrap Therapy for Low
Back Pain
Before using heat therapy to treat LBP, it is important to rule out any serious systemic
disease [45]. In a review of nine studies, including a total of 1117 patients, French et al.
indicated that the continuous application of low-level heat directly to the skin via a heat
wrap was shown to provide small, short-term improvements in pain and mobility [16].
Therefore, heat therapy represents a viable approach to the self-treatment of acute or
chronic muscular LBP, either alone or as a part of a multimodal approach.
In a prospective study, patients with acute, non-specific LBP were randomized to
receive continuous low-level heat wrap therapy for 8 h/day (n = 113), acetaminophen
(n = 113), or ibuprofen (n = 106). Pain relief was reported in all three treatment groups, and
was significantly greater with heat wrap therapy than with acetaminophen or ibuprofen
throughout two days of treatment (p < 0.001 for all) and two days of follow-up (p < 0.001
for all). This translated into significant differences in pain relief scores of 33% for heat
wrap vs. acetaminophen and 52% for heat wrap vs. ibuprofen. The heat wrap group also
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experienced significantly greater reductions in muscle stiffness and significantly greater
improvements in lateral trunk flexibility and disability scores vs. the acetaminophen and
ibuprofen groups after both the treatment and follow-up periods [46].
In another prospective trial, participants with acute LBP were randomized to receive
heat wrap therapy (8 h/day for three consecutive days; n = 95) or oral placebo (n = 96).
Heat wrap therapy resulted in significantly greater pain relief than oral placebo on Day 1
(p < 0.001; treatment difference of 68%); this extended to the end of the two days of follow-
up (p < 0.0001). Pain relief correlated with other outcomes, in that a similar pattern
was observed for muscle stiffness and lateral trunk flexibility, with significantly greater
improvements in the heat wrap group vs. the oral placebo group on Day 1 through to the
end of follow-up, as well as in disability scores from Day 3 [47]. A similar trial investigated
the overnight use of a heat wrap in 76 patients with acute LBP. The overnight application
(~8 h) of heat therapy for three nights was found to be significantly more effective at
reducing pain during the following day and during the two days post-treatment than
an oral placebo. Similarly, significant improvements were noted with a heat wrap vs.
placebo for morning muscle stiffness, daytime muscle stiffness, pain–affect scores, and
disability scores during treatment and follow-up. Furthermore, lateral trunk flexibility
was significantly improved in the heat wrap group vs. in the placebo group at the end of
treatment, and sleep scores were higher for the heat wrap group [48].
In two workplace studies, heat wrap therapy was found to significantly reduce pain
intensity in patients with acute LBP, both during treatment and up to two weeks after its
use [49,50]. Heat wrap therapy also reduced the impact of pain on everyday activities, most
notably the ability to lift, work performance, and quality of sleep, and provided sufficient
pain relief for most patients during treatment and two weeks after its use [49].
Heat wrap therapy has also been investigated as part of a multimodal approach in
acute and chronic settings. In a prospective outpatient study that combined continuous
heat wrap therapy with directional preference-based exercise, 100 patients with acute LBP
were randomized to a heat wrap alone (~8 h/day for five days), exercise alone, a heat wrap
plus exercise, or an educational booklet (control). Treatment lasted for five consecutive
days, and patients were followed up for an additional two days. On Day 7, the functional
improvement with a heat wrap plus exercise was 84%, 95%, and 175% higher than a heat
wrap alone, exercise alone, or the control, respectively. By Day 7, the heat wrap plus
exercise group had also achieved a significantly lower deficit from pre-injury function and
a greater reduction in disability than all of the other treatment groups. Furthermore, the
heat wrap plus exercise group was associated with significantly greater pain relief when
compared with the exercise alone and control groups [51].
Although most studies of heat wrap therapy have examined its used in patients
with acute LBP, heat wrap treatment has also been shown to have benefits in patients
with chronic LBP. Within a multimodal approach trial of chronic LBP, 176 patients were
randomized to receive basic multimodal treatment either alone or supplemented with
heat wrap therapy. While range of movement and flexibility improved in both groups,
after 12 weeks of treatment, the supplemented group recorded greater improvements in
their strength parameters (extension and right/left rotation) than the non-supplemented
group [29]. This supports previously reported short-term improvements in physical and
psychological wellbeing associated with heat wrap therapy in the chronic setting [52].
The long-term effects of combining heat wrap therapy with exercise are currently under
investigation for the management of acute LBP (ClinicalTrials.gov: NCT03986047). In
this trial, patients will be randomly assigned to receive heat wrap therapy alone, exercise
alone, or heat wrap plus exercise for seven days continuously, and will be followed for
24 weeks [53].
While most studies rely on subjective patient-reported scoring, Kettenmann et al.
employed a spontaneous electroencephalogram (EEG) as an objective parameter alongside
the self-assessment of pain [54]. Patients were randomized to oral analgesic as a rescue
therapy (control; n = 15) or heat wrap therapy (≥4 h/day on four consecutive days) plus
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oral analgesic rescue therapy (n = 15). The heat wrap group had a shift of spontaneous
EEG activity to lower frequency bands, indicating reduced arousal that was not observed
in the control group. This is consistent with patient reporting, whereby heat therapy
significantly reduced perceived pain vs. the control group. The heat wrap group also
reported significant improvements in stress and quality of sleep [54].
In Table 2, we summarize some of the key trials that have examined the efficacy of
continuous low-level (~40 ◦C) heat wrap treatment for the relief of acute or chronic LBP.
There were no serious adverse events reported in any of the aforementioned studies, and
heat wrap therapy was found to be well tolerated in all of the studies mentioned [46–48,50,55].
Cost-effectiveness analyses have shown that the use of heat wrap therapy for the man-
agement of LBP is beneficial to both healthcare systems [56] and employers [49]. Economic
modeling of the heat wrap vs. acetaminophen vs. ibuprofen study described above [46]
indicates that introducing heat wrap therapy in place of oral treatments would provide
material savings to the U.K.’s National Health Service [56]. Furthermore, a pharmacoeco-
nomic analysis has demonstrated the improved workplace productivity, and subsequent
benefit to employers, associated with heat wrap therapy [49].
Table 2. Evidence for the effectiveness of heat wrap therapy in the treatment of low back pain.
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6. Other Applications for Superficial, Low-Level Heat Therapy
The muscle relaxant and analgesic effects of superficial low-level heat therapy (as
reviewed in the section above) have also been found to be efficacious in relieving other types
of musculoskeletal pain. Several studies have reported the benefits of continuous, low-level,
direct heat wrap therapy for the treatment of neck pain [28,57], knee pain (including pain
from osteoarthritis, where a heat wrap was more effective than acetaminophen) [57–60],
and wrist pain stemming from strain or sprain, tendinosis, and carpal tunnel syndrome,
with particularly good results observed in patients with carpal tunnel syndrome [61].
Localized heating of certain trigger points has also proven effective at relieving neck
pain; in this case, the heat is applied on the upper trapezius muscle [28]. Studies have also
indicated that heat therapy is effective at preventing and treating delayed-onset muscle
soreness associated with exercise, with benefits observed in younger and older patients, as
well as those with diabetes (a group who reportedly experience greater muscle soreness
after exercise) [57,62–64]. In addition, the application of heat therapy for 8 h, including
the 4 h before exercise, was found to be significantly more effective than stretching at
preventing pain and improving disability and physical function the day after exercise [62].
Further to this, studies have also indicated that heat therapy provides greater benefits than
cold therapy when applied after exercise [62–65].
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Heat wraps as a method of heat therapy for pain relief have shown the key advantage
of wearability, which allows for continuous use and the rapid resumption of work/normal
daily activities. This feature makes it particularly relevant for other areas of pain manage-
ment, such as dysmenorrhea, where it has demonstrated pain relief comparable to that
achieved with ibuprofen [66,67]. Heat therapy may also be beneficial as part of a long-term
pain management strategy following some surgical procedures [68].
7. Conclusions
LBP exerts a substantial burden on patients and is recognized as a major public health
concern. Early treatment can help to inhibit the transition from acute to chronic LBP. Several
clinical trials have demonstrated that continuous, low-level heat therapy, used alone or as
part of a multimodal approach, provides early pain relief and improves muscular strength
and flexibility, facilitating a return to normal function in patients with either acute or
chronic LBP. Although improvements seen with superficial heat therapy can be short-
term, local heat therapy can have a valuable role in current clinical practice, particularly
for complex clinical cases, such as elderly patients with multiple comorbidities who are
already receiving several concomitant medications, and in the outpatient setting for the
preparation and follow-up of back pain therapies. In patients with mild LBP, heat therapy
may potentially negate the use of pain medications, and in patients with moderate-to-severe
pain, heat therapy may help lower pain drug requirements (i.e., number and dose).
In conclusion, continuous, low-level superficial heat therapy is an effective, safe,
easy-to-use, and cost-effective non-pharmacological pain relief option that patients can
easily self-administer, proving that a therapy known for centuries still has a relevant role
in clinical practice today.
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